Age is an important factor in the diagnosis and prognosis of Acute Myeloid Leukemia (AML). AML is a type of cancer that affects the blood and bone marrow, and is the most common type of acute leukemia in adults.
AML is most commonly found in adults aged 60-65, with the median age of diagnosis for AML being 67. Older adults are at a significantly higher risk for developing AML, with the risk of developing the disease increasing with age. Those aged 85 and older are at the highest risk for developing AML, with an incidence of 12.1 per 100,000 persons.
AML is also seen in younger adults, with the incidence increasing with age. The incidence of AML is highest in adults aged 45-49, with an incidence of 4.1 per 100,000 persons. The incidence declines after the age of 65, with an incidence of 1.7 per 100,000 persons in those aged 80-84.
AML is also seen in children, with an incidence rate of 1.2 per 100,000 persons in those aged 0-14. The incidence of AML in children is highest in those aged 5-9, with an incidence rate of 2.5 per 100,000 persons.
In conclusion, age is an important factor in the diagnosis and prognosis of Acute Myeloid Leukemia (AML). Those aged 60-65 are at an increased risk for developing AML, with the risk increasing with age. AML is also seen in younger adults and children, with the incidence of the disease increasing with age in both groups.